Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance
Loading...
Date
Authors
Hofmockel, G.
Wittmann, A.
Dammrich, J.
Bassukas, I. D.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Type
Type of the conference item
Journal type
peer-reviewed
Educational material type
Conference Name
Journal name
Anticancer Res
Book name
Book series
Book edition
Alternative title / Subtitle
Description
p53 tumor suppressor gene mutations are present in a wide variety of human cancers, and the bcl-2 gene product is considered to prevent apoptosis. However, the significance of these gene products for the aggressiveness of the tumor and correspondingly for the prognosis of patients with renal cell carcinoma (RCC) is unclear. The expression of p53 and bcl-2 gene products was studied immunohistochemically using formalin-fixed paraffinembedded tumor samples of 31 locally confined RCC of patients treated with radical nephrectomy. The significance of these 2 parameters, in addition to tumor stage and malignancy grade, was tested with regard to survival and time of no recurrence using Kaplan-Meier-plots by the log rank test or Tarone's test and the Cox multiple hazard regression analysis (mean follow-up 5.4 years). Only 5 of the 31 RCCs stained positively for p53 and only 2 showed positive bcl-2 staining of tumor cells. Tumor stage (P < 0.002) and malignancy grade (P < 0.007) were statistically significant prognostic parameters for both survival and disease-free period by univariate analysis. In contrast, the detection of either p53 (P > 0.67) or bcl-2 gene product (P > 0.28) had no prognostic impact. Also in the multivariate statistical analysis, neither of the 2 parameters i.e. p53 and bcl-2 expression significantly improved the prognostic impact of the conventional prognosticators stage and grade, if applied in addition. The expression of p53 and bcl-2 seems unimportant as a prognostic factor in locally confined RCCs.
Description
Keywords
Adult, Aged, Carcinoma, Renal Cell/genetics/*metabolism/pathology, Female, Gene Expression Regulation, Neoplastic, Genes, bcl-2/*genetics, Genes, p53/*genetics, Humans, Kidney Neoplasms/genetics/*metabolism/pathology, Male, Middle Aged, Multivariate Analysis, Neoplasm Staging, Prognosis, Proto-Oncogene Proteins c-bcl-2/*metabolism, Tumor Suppressor Protein p53/*metabolism
Subject classification
Citation
Link
http://www.ncbi.nlm.nih.gov/pubmed/9042262
Language
en
Publishing department/division
Advisor name
Examining committee
General Description / Additional Comments
Institution and School/Department of submitter
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής